Clinical trial · Interventional
Dibenzyl Trisulphide (GUINEAHEN WEED) for Stage IV Cancer
Use of Dibenzyl Trisulphide as a Chemotherapeutic Agent in Stage Four Cancer of the Breast, Prostate, Cervix and Colon
NCT04113096CI-TRIAL-00041039unknownEarly Phase 1ClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This study is being done to find the effect of Dibenzyl Trisulphide (active ingredient in Guinea Hen Weed in combination in patients with stage four cancer of the breast, prostate, cervix and colon.
Conditions
Conditions (4)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Stage IV Breast Cancer | Malignant Breast Neoplasm | CURATED_BROADER | 0.78 |
| Stage IV Cancer of the Cervix | Malignant Cervical Neoplasm | CURATED_BROADER | 0.78 |
| Stage IV Colon Cancer | Malignant Colon Neoplasm | CURATED_BROADER | 0.78 |
| Stage IV Prostate Cancer | Malignant Prostate Neoplasm | CURATED_BROADER | 0.78 |
Interventions
Interventions (5)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Cancer of the Prostate Placebo | Drug | — | UNRESOLVED |
| Cervical Cancer Stage IV Placebo | Drug | — | UNRESOLVED |
| Dibenzyl trisulphide capsules | Drug | — | UNRESOLVED |
| Stage IV Breast Cancer Placebo | Drug | — | UNRESOLVED |
| Stage IV: Colon Cancer Placebo | Drug | — | UNRESOLVED |
Design
Arms and outcomes
Arms (4)
- type
- EXPERIMENTAL
- label
- Breast Cancer Stage IV
- description
- Stage IV Breast Cancer: Dibenzyl trisulphide capsules (20mg once daily)/6 months
- interventionNames
- Drug: Dibenzyl trisulphide capsules
- Drug: Stage IV Breast Cancer Placebo
- type
- EXPERIMENTAL
- label
- Colon Cancer Stage IV
- description
- Stage IV Colon Cancer:Dibenzyl trisulphide capsules (20 mg one daily for 6 months
- interventionNames
- Drug: Dibenzyl trisulphide capsules
- Drug: Stage IV: Colon Cancer Placebo
- type
- EXPERIMENTAL
- label
- Cervical Cancer Stage IV
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 12 Years
Show eligibility criteria text
Inclusion Criteria: * Age: Greater than 12 years. * Documented histologic evidence of cancer * Staged as stage IV * World Health Organization (WHO) Performance Status of between 0 and 2 * Radiological confirmation of metastases with bone scan or X ray, CT and/or MRI scan Exclusion Criteria * Cancer stages less than stage 4 * Pregnant women * Children 0 - 12 years
References
Publications (0)
Data not yet available
No reference posted for this study.